In a significant step forward for India’s cancer treatment, Immuneel Therapeutics (Immuneel), proudly unveils Qartemi®, country’s first global CAR T-cell therapy for adult B-cell Non-Hodgkin Lymphoma (B-NHL). A personalized therapy for adult patients with relapsed or refractory B-NHL, Immuneel, India’s leading cell and gene therapy start-up, addresses a critical gap in India’s cancer immunotherapy landscape. This groundbreaking therapy—benchmarked to global […]
CAR-T Cell Therapy in Blood Cancers: Unleashing the Power of Immune Cells
Dr. Natraj K S, Senior Consultant – Hematology, HCG Cancer Hospitals, KR Road, Bangalore. Blood cancer, also known as hematologic cancer, is a type of cancer that begins in the cells of the blood-forming tissues, such as the bone marrow, lymphatic system, and blood cells. It affects the production and function of blood cells. There […]